PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|March 30, 2016
Filling and Stoppering Machine for Nested Syringes Revealed at INTERPHEX 2016
Author(s)Pharmaceutical Technology Editors
Marchesini Group’s Extrafill, a filling and stoppering machine, contains a robotic arm gripper system designed to move like a human hand.
Advertisement
The Marchesini Group, a pharmaceutical packaging company headquartered in Italy with facilities in New Jersey (US), announced that the company will be showcasing Extrafill, a filling and stoppering machine for nested syringes, at INTERPHEX 2016. Extrafill is a new addition to the company’s syringe filling product line. The machine can accommodate from two to five stoppering stations and can produce 12000 pieces per hour. The machine is also equipped with peristaltic filling pumps and a statistical check by a batch weigher.
All production phases are integrated into one monobloc unit designed to combine the two tub opening and syringe filling/stoppering operations under one isolator. Once loaded on the machine, the tub passes under the system that heats the lidding edges. The tub then passes under the opening station where a robotic arm peels off the Tyvek protective film and pushes it onto a loading belt to continue towards the filling and stoppering stations.
The robot arm is a gripper system designed to move like a human hand. Both the mechanical software of the delidding (peeling) systems have been developed by Marchesini’s R&D team with the aim of devising a specific robotized system capable of handling the product efficiently in sterile conditions.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement